EuroPCR 2018: Low incidence of cardiovascular mortality with Centera self-expanding valve at one year

Hermann Reichenspurner (Departments of Cardiovascular Surgery and General and Interventional Cardiology, University Heart Center, Hamburg, Germany) at EuroPCR (22 May—25 May, Paris, France) reported...

EuroPCR 2018: No significant difference in bioprosthetic valve dysfunction between surgical and TAVI devices...

The NOTION trial (Nordic aortic valve intervention) was the first comparison of surgical and transcatheter aortic valve implantation (TAVI) in patients at lower surgical...

EuroPCR 2018: Real-world data confirm trial outcomes for Sapien 3

Thirty-day data presented at EuroPCR (22 May—25 May, Paris, France) show consistently positive patient outcomes for patients undergoing transcatheter aortic valve implantation (TAVI) with...

ADVERTORIAL: Sentinel Cerebral Protection System provides reassurance to both physicians and patients

Compared with first-generation devices, new-generation transcatheter aortic valve implantation (TAVI) devices—along with iterative approaches in technique and imaging—have partially reduced the documented stroke rates...

Ron Waksman

Justin Davies

Francesco Maisano

(Visited 1,535 times, 1 visits today)